Page last updated: 2024-11-03

probenecid and Thymoma

probenecid has been researched along with Thymoma in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Thymoma: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Echevarria-Lima, J1
Kyle-Cezar, F1
P Leite, DF1
Capella, L1
Capella, MA1
Rumjanek, VM1

Other Studies

1 other study available for probenecid and Thymoma

ArticleYear
Expression and activity of multidrug resistance protein 1 in a murine thymoma cell line.
    Immunology, 2005, Volume: 114, Issue:4

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; CD4-Positive

2005